Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment

Clinical Immunology

Volumn 99, Issue 3, 2001, Pages 308-319

  Sime, Patricia J ^a   O’reilly, Katherine M A ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

CD40 ligand; Fibrosis; TGF ; Th1 cytokines; Th2 cytokines

Indexed keywords

CD4 ANTIGEN; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; GAMMA1B INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ASTHMA; CLINICAL TRIAL; FIBROGENESIS; HUMAN; LUNG DISEASE; LUNG FIBROSIS; MOUSE; MULTICENTER STUDY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW; TH1 CELL; TH2 CELL;

EID: 0035020567     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5008     Document Type: Review

References (103)

1. Lung inflammation and fibrosis
2. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
3. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4
4. Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. Potential role in fibrosis
5. Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis
6. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells
7. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors
8. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation
9. Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets
10. Selective inhibition of collagen gene expression in fibroblasts by an interferon-gamma transgene
11. Interferon-gamma regulates collagen and fibronectin gene expression by transcriptional and post-transcriptional mechanisms
12. Regulation of interferon-gamma production by IL-12 and IL-18
13. Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: Macrophages as a prominent source of interleukin-4
14. Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat
15. Lung interleukin-5 expression in murine bleomycin-induced pulmonary fibrosis
16. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis
17. The role of IL-5 in bleomycin-induced pulmonary fibrosis
18. Chemotactic cytokines mediate leukocyte recruitment in fibrotic lung disease
19. Lung fibrosis induced by silica particles in NMRI mice is associated with an upregulation of the p40 subunit of interleukin-12 and Th-2 manifestations
20. Role of interleukin-10 in the lung response to silica in mice
21. Interferon-gamma production by specific lung lymphocyte phenotypes in silicosis in mice
22. Altered accessory cell function of alveolar macrophages: A possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis
23. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis
24. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells
25. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis
26. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung
27. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases
28. Evaluation of CD30 as a marker for Th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases
29. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA)
30. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis
31. Repair mechanisms in asthma
32. Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction
33. Increased levels of interleukin-18 in patients with pulmonary sarcoidosis
34. The value of interleukin-12 as an activity marker of pulmonary sarcoidosis
35. Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis
36. Cytokine mRNA gene expression in active and nonactive pulmonary sarcoidosis
37. IL-12 modulates expression of hypersensitivity pneumonitis
38. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis
39. Mediators of hypersensitivity pneumonitis
40. A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice
41. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response
42. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: Downregulation of TGF-beta and procollagen I and III gene expression
43. Interferon-gamma inhibits experimental renal fibrosis
44. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis
45. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases
46. Treatment of systemic sclerosis with gamma-interferon
47. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection
48. Cytokines and pulmonary fibrosis
49. Pulmonary fibrosis and its treatment: Today and in the next millennium
50. Interstitial and bronchial fibroblasts
51. Latent transforming growth factor-β from human platelets: A high molecular weight complex containing precursor sequences
52. Latent high molecular weight complex of transforming growth factor β1: Purification from human platelets and structural characterization
53. Proteolytic activation of latent transforming growth factor β from fibroblast-conditioned medium
54. Inflammatory and immunomodulatory roles of TGFβ
55. Molecule of the month. TGFβ; A key modulator of immune cell function
56. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
57. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression
58. Transforming growth factor-β
59. Transforming growth factor-β1 induces α-smooth actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
60. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis
61. Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis
62. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury
63. Lung cytokine production in bleomycin-induced pulmonary fibrosis
64. Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasis, and lung cancer
65. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation
66. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis
67. TGF-β1, but not TGF-β2 or TGF-β3, is differentially expressed in epithelial cells of advanced pulmonary fibrosis: An immunohistochemical study
68. Immunohistochemical localization of transforming growth factor β isoforms in asbestos-related diseases
69. Adenoviral-mediated gene transfer of active TGF-beta 1 induces prolonged aggressive fibrosis in rat lung
70. Transient gene transfer and expression in the lung
71. The integrin alpha v beta 6 binds and activates latent TGF beta1: A mechanism for regulating pulmonary inflammation and fibrosis
72. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells
73. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-β-like molecule by plasmin during co-culture
74. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts
75. Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation
76. Effect of transforming growth factor beta on a bleomycin induced accumulation of lung collagen in mice
77. Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters
78. Negative regulation of transforming growth factor -β by the proteoglycan decorin
79. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
80. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere
81. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin
82. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
83. The CD40 antigen and its ligand
84. Immunoregulatory role of CD40 in human B cell differentiation
85. The biology of the human ligand for CD40
86. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production
87. CD40 expression by human fibroblasts
88. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation
89. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
90. Activation of human dendritic cells through CD40 cross-linking
91. Expression of functional CD40 by vascular endothelial cells
92. CD40 ligand on activated platelets triggers and inflammatory reaction of endothelial cells
93. CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts
94. A new view of prostaglandin E regulation of the immune response
95. Blockade of CD40-CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis
96. Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome
97. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: Role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production
98. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
99. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
100. Ligation of CD40 induced tumor necrosis factor-alpha in rheumatoid arthritis: A novel mechanism of activation of synoviocytes
101. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: Preservation of kidney function
102. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseases